Amylin's Other Profit Injection
What I hear is that the pharma industry (and Wall Street) is holding its breath for Amylin's next big thing: Exenatide (produced in partnership with Eli Lilly & Co.). This is another injectable product (derived from lizard saliva, of all thing... (Source: Diabetes Mine)
Source: Diabetes Mine - March 21, 2005 Category: Endocrinology Authors: Amy Tenderich Source Type: blogs